Replies to post #170143 on Biotech Values

[DewDiligence]

ENTA—Thanks for weighing in. If the non-ribavirin arms of PEARL-2/3/4 come in as you expect, my valuation arithmetic in #msg-92234861 may prove to be unduly low :- )